Daily BriefsMost Read

Most Read: Tata Capital Limited, Zhejiang Leapmotor Technologie, Teco Electric & Machinery, Yum China Holdings , Innovent Biologics Inc, Daehan Shipbuilding, Tsuruha Holdings, Zijin Gold, Dynamatic Technologies, Shanghai Shenzhen CSI 300 Index and more

In today’s briefing:

  • AMFI Stock Reclassification Preview (Dec 2025): New Listings Shaking Up the Rankings
  • HSTECH Index Rebalance: Leapmotor (9863 HK) To Replace ASMPT (522 HK) As Trade Hits US$3.5bn
  • Yuanta/P-Shares Taiwan Div+ ETF Rebalance Preview: 3 Changes; US$4bn Trade
  • HSCEI Index Rebalance: 3 Changes; Yum China In; Double Add for Innovent Bio
  • Hang Seng Index (HSI) Rebalance: Innovent Biologics Turns a Profit, Gets Added
  • KOSPI Size Indices: Lots of Change as Averaging Starts
  • Curator’s Cut: Powering Down CATL, Iron Ore Plays & Japan Consumer Consolidation
  • Hong Kong: IPO SPOTLIGHT – OVERVIEW 2025
  • The Beat Ideas: Dynamatic Technologies – An Indian Tier-1 Supplier’s Flight Path in Global Aerospace
  • CSI 300 (SHSZ300) Tactical Outlook After Nov. 28 Rebalance Announcement


AMFI Stock Reclassification Preview (Dec 2025): New Listings Shaking Up the Rankings

By Brian Freitas

  • We forecast 7 stocks moving from MidCap to LargeCap, 10 stocks moving from LargeCap to MidCap, 3 stocks from SmallCap to MidCap, and 11 stocks from MidCap to SmallCap.
  • From the new listings, 13 stocks are expected to be added to Large Cap, 5 stocks are expected to be added to Mid Cap, and multiple stocks to Small Cap.
  • With the review period nearing completion, there could still be more outperformance given the momentum, but we would look to take profit on the stocks as the divergence gets wider.

HSTECH Index Rebalance: Leapmotor (9863 HK) To Replace ASMPT (522 HK) As Trade Hits US$3.5bn

By Brian Freitas


Yuanta/P-Shares Taiwan Div+ ETF Rebalance Preview: 3 Changes; US$4bn Trade

By Brian Freitas

  • With the review period now complete, there could be 3 constituent changes for the Yuanta/​P-Shares Taiwan Dividend Plus ETF in December.
  • Constituent changes along with capping changes will lead to a one-way turnover of 12.7% and in a round-trip trade of TWD 125bn (US$4bn).
  • There are multiple stocks that have same-way or opposite flow from trackers of other Taiwan indices and present some interesting trading opportunities.

HSCEI Index Rebalance: 3 Changes; Yum China In; Double Add for Innovent Bio

By Brian Freitas


Hang Seng Index (HSI) Rebalance: Innovent Biologics Turns a Profit, Gets Added

By Brian Freitas


KOSPI Size Indices: Lots of Change as Averaging Starts

By Brian Freitas

  • The review period for the March rebalance of the KOSPI Size Indices will commence on 1 December and will end on 28 February.
  • Nearing the start of the averaging period, we forecast 34 migrating stocks. Among new listings, 1 stock could be added to LargeCap, 2 to MidCap and 2 to SmallCap.
  • The upward migrations have outperformed the downward migrations by a lot over the last 3 months. The gap in returns versus the KOSPI2 INDEX is a lot smaller.

Curator’s Cut: Powering Down CATL, Iron Ore Plays & Japan Consumer Consolidation

By Pranav Rao

  • Welcome to Curator’s Cut — a fortnightly roundup of standout themes from the 1,500+ insights published on Smartkarma.
  • In this cut, we review CATL’s H-share lock-up expiry, iron ore equity opportunities in the face of Simandou’s expected supply, and the accelerating consolidation in Japan’s consumer sector.
  • Want to dig deeper? Comment or message with the themes you’d like to see highlighted next.

Hong Kong: IPO SPOTLIGHT – OVERVIEW 2025

By David Mudd

  • Hong Kong is the top global destination for IPOs in 2025, with over HK $280 billion raised so far.  Large scale A+H dual listings have surged this year.
  • Technology and healthcare sectors have dominated IPOs with the materials sector also floating several large listings.  With nearly 300 listings in the pipeline, 2026 should be another banner year.
  • Zijin Gold (2259 HK) , Chery Automobile (9973 HK) and Mixue Group (2097 HK) were the largest IPOs of the year while PegBio (2565 HK) has had the best return.

The Beat Ideas: Dynamatic Technologies – An Indian Tier-1 Supplier’s Flight Path in Global Aerospace

By Nimish Maheshwari

  • The structural shift in Dynamatic Technologies’ revenue mix is accelerating, with the high-margin Aerospace segment now contributing 82% of consolidated EBITDA in FY25, underpinned by major new contract industrialization.
  • The premium valuation is justified by its annuity-like, high-barrier sole-supplier status for the Airbus A320 family and significant new program wins (Airbus A220 doors), providing a multi-decade visibility.
  • DTL’s core value is increasingly diverging from its legacy segments; success hinges on efficient capital deployment in India and mitigating the persistent drag from its European Metallurgy business.

CSI 300 (SHSZ300) Tactical Outlook After Nov. 28 Rebalance Announcement

By Nico Rosti

  • On November 28th China Securities Index Co (CSI) announced the changes to the CSI 300 Index (SHSZ300 INDEX): 11 companies added and 11 deleted.
  • The complete list of additions and deletions is available here (or see the attachment at the end of this insight for your convenience).
  • We analyze our probabilistic models to forecast short-term market directions for the CSI 300 Index, as passive flows between here and December 12 may affect the index volatility and trend.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars